Haemonetics Corp (HAE) - Comprehensive Stock Analysis & Investment Research
Deep dive into Haemonetics Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Haemonetics Corp Investment Summary
When evaluating whether Haemonetics Corp (HAE) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Haemonetics Corp (HAE) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. The company employs approximately 3,300 people. With a market capitalization of $3 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.
Financial Performance Analysis
Our comprehensive financial analysis covers Haemonetics Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Haemonetics Corp along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Haemonetics Corp is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Haemonetics Corp (Stock Symbol: HAE) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Haemonetics Corp's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Haemonetics Corp...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Haemonetics Corp...
Revenue & Growth Analysis
Haemonetics Corp generates annual revenues of $1 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Haemonetics Corp...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Haemonetics Corp...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Haemonetics Corp...
Strategic Market Position
Haemonetics Corp strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.
Industry Competitive Landscape
Haemonetics Corp competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company shows positive operational efficiency through free cash flow generation of $76 million annually , with year-over-year cash flow growth of -31.2%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.
Margin & Pricing Power Analysis
The company maintains a 53.0% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.
Operating margin of 14.8% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This healthy operating margin shows balanced investment in growth functions while maintaining reasonable profitability.
Asset Utilization Efficiency
Asset turnover ratio of 0.54x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.
Financial Strength & Leverage
Current ratio of 1.71 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.